Breaking News Instant updates and real-time market news.

AVMXY

Avita Medical

$0.00

(0.00%)

19:24
10/15/18
10/15
19:24
10/15/18
19:24

Avita Medical announces Recell trial results presentation

AVITA Medical announced that a medical education symposium on the use of the RECELL Autologous Cell Harvesting Device was held at the U.S. Midwest Region Burn Conference in Minneapolis. The symposium was led by Jeffrey Carter, MD, FACS, Medical Director of University Medical Center New Orleans Burn Center and Associate Professor of Surgery at LSU Health New Orleans School of Medicine. Dr. Carter also presented at the conference the results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical benefits of the RECELL System. The FDA recently approved the RECELL System to treat acute thermal burns in patients 18 years and older. The medical symposium was organized as the first step in training U.S. physicians who had not previously treated patients with the RECELL System in advance of FDA approval in clinical trials or in the Compassionate Use program. The Midwest Region Burn Conference is one of the series of conferences sponsored by the American Burn Association each year.

AVMXY Avita Medical
$0.00

(0.00%)

10/04/18
LSCM
10/04/18
INITIATION
Target $4
LSCM
Buy
Avita Medical assumed with a Buy at Lake Street
Lake Street analyst Brooks O'Neil assumed coverage of Avita Medical with a Buy rating and $4 price target. The company's Recell System, which received FDA approval on September 21 to treat severe thermal burns in patients 18 years and older, dramatically" improves patient outcomes, shortens length of stay, lowers treatment costs and improves productivity for doctors, O'Neil tells investors in a research note. The analyst believes this win/win/win/win solution" is the first meaningful innovation in burn care in more than 20 years.

TODAY'S FREE FLY STORIES

CVS

CVS Health

$79.92

-0.9 (-1.11%)

08:04
11/15/18
11/15
08:04
11/15/18
08:04
Hot Stocks
CVS Health announces new collaboration with Philadelphia Job Corps »

CVS Health has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSMT

PriceSmart

$66.24

-0.53 (-0.79%)

08:04
11/15/18
11/15
08:04
11/15/18
08:04
Hot Stocks
PriceSmart to build a new warehouse club in Panama »

PriceSmart signed a lease…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMRK

Landmark Infrastructure

$13.46

0.32 (2.44%)

08:03
11/15/18
11/15
08:03
11/15/18
08:03
Hot Stocks
Landmark Infrastructure board approves $20M unit purchase program »

Landmark Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGEN

Seattle Genetics

$53.11

-1.73 (-3.15%)

08:03
11/15/18
11/15
08:03
11/15/18
08:03
Hot Stocks
Seattle Genetics receives Breakthrough Therapy Designation for ADCETRIS »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 03

    Dec

CUB

Cubic

$63.93

-1.4 (-2.14%)

08:03
11/15/18
11/15
08:03
11/15/18
08:03
Earnings
Cubic sees FY19 revenue $1.37B-$1.45B, consensus $1.3B »

Sees FY19 adjusted EBItDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CUB

Cubic

$63.93

-1.4 (-2.14%)

08:02
11/15/18
11/15
08:02
11/15/18
08:02
Earnings
Cubic reports Q4 EPS 80c vs. 35c last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BIG

Big Lots

$42.56

-1.46 (-3.32%)

08:01
11/15/18
11/15
08:01
11/15/18
08:01
Options
Big Lots put buyer realizes 16% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$64.33

5.73 (9.78%)

08:00
11/15/18
11/15
08:00
11/15/18
08:00
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

07:59
11/15/18
11/15
07:59
11/15/18
07:59
Upgrade
Mylan rating change  »

Mylan upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$65.09

-2.22 (-3.30%)

07:59
11/15/18
11/15
07:59
11/15/18
07:59
Recommendations
Alnylam analyst commentary  »

Alnylam management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

CUBE

CubeSmart

$29.75

0.46 (1.57%)

07:57
11/15/18
11/15
07:57
11/15/18
07:57
Upgrade
CubeSmart rating change  »

CubeSmart upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$64.33

5.73 (9.78%)

07:56
11/15/18
11/15
07:56
11/15/18
07:56
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KREF

KKR Real Estate Finance

$20.56

-0.06 (-0.29%)

07:55
11/15/18
11/15
07:55
11/15/18
07:55
Syndicate
KKR Real Estate Finance 4.5M share Spot Secondary priced at $20.15 »

Morgan Stanley, Wells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

LBTYA

Liberty Global

$24.27

0.6 (2.53%)

07:53
11/15/18
11/15
07:53
11/15/18
07:53
Periodicals
Liberty Global CFO says it is not desperate to divest UPC unit, Reuters reports »

Liberty Global is not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ALB

Albemarle

$99.95

0.72 (0.73%)

07:53
11/15/18
11/15
07:53
11/15/18
07:53
Initiation
Albemarle initiated  »

Albemarle initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

PRQR

ProQR Therapeutics

$17.82

-0.84 (-4.50%)

, ONCE

Spark Therapeutics

$40.93

-1.81 (-4.23%)

07:52
11/15/18
11/15
07:52
11/15/18
07:52
Initiation
ProQR Therapeutics, Spark Therapeutics initiated  »

ProQR Therapeutics…

PRQR

ProQR Therapeutics

$17.82

-0.84 (-4.50%)

ONCE

Spark Therapeutics

$40.93

-1.81 (-4.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:50
11/15/18
11/15
07:50
11/15/18
07:50
General news
U.S. retail sales preview: »

U.S. retail sales…

O

Realty Income

$63.17

0.32 (0.51%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRC

Spirit Realty

$8.04

-0.065 (-0.80%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Spirit Realty rating change  »

Spirit Realty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECC

Eagle Point Credit

$17.34

-0.155 (-0.89%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Eagle Point Credit rating change  »

Eagle Point Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFE

Safety, Income and Growth

$18.97

(0.00%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Safety, Income and Growth rating change  »

Safety, Income and Growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$25.66

-7.04 (-21.53%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
PG&E rating change  »

Morgan Stanley cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPRT

Essential Properties Realty Trust

$13.96

-0.15 (-1.06%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Essential Properties Realty Trust rating change  »

Essential Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$44.35

-0.78 (-1.73%)

07:48
11/15/18
11/15
07:48
11/15/18
07:48
Recommendations
Cisco analyst commentary  »

Value investors should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Jan

WLK

Westlake Chemical

$71.23

0.07 (0.10%)

07:48
11/15/18
11/15
07:48
11/15/18
07:48
Recommendations
Westlake Chemical analyst commentary  »

Westlake Chemical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.